Incidence, outcomes, and management of bleeding in non-ST-elevation acute coronary syndromes.
Antithrombotic and antiplatelet drugs and percutaneous interventions have decreased the ischemic outcomes of non-ST-elevation acute coronary syndromes, but they pose risks of bleeding. The authors review the scope of the problem and ways to prevent and manage bleeding in this situation.
Gutierrez
Antonio
A
Duke University Medical Center, 2301 Erwin Road, Durham, NC 27710, USA. antonio.gutierrez@duke.edu
Rao
Sunil V
SV
D054058:Acute Coronary Syndrome / Q000150:complications* / Q000188:drug therapy*; D005343:Fibrinolytic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006470:Hemorrhage / Q000139:chemically induced* / Q000209:etiology*; D006801:Humans; D015994:Incidence; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D011379:Prognosis; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors